Amarin Corp Plc (AMRN)

[Nukemtiltheyglow]

rose; IMHO, Amarin can't be sold quickly enough. Taking Insurance Companies to court is not in the playbook for the current Amarin Management Team. These shysters (insurance Companies) will tie this "infringement" case up in court for years.

With only a few more years of Patent Protection, New Drug Exclusivity (NDE) "tongue in cheek". Patents? "We don't need no stinking Patents" (Blazing Saddles). A Pharmaceutical company with more time and money needs to step in and do it, only if they choose to. Tying things up in court while trying to advertise your product requires deeper pockets than what Amarin has currently.

There is value still in Vascepa. Those of us who are taking it, are a witness to it's effects. Subtle perhaps, but still effective in lowering our risk of a CVD event. Of course I'm preaching to the choir. The word needs to get out on the street. Amarin management has not been effective in doing this.